Drug Approval | December 27, 2025
Chugai’s Tecentriq gets green light in Japan for hard-to-treat Thymic Carcinoma
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Subscribe To Our Newsletter & Stay Updated